propranolol has been researched along with Carcinoma, Epidermoid in 15 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The multistep process of oral carcinogenesis provides a biological rationale for the use of chemoprevention in individuals at increased risk of developing oral cancer." | 5.62 | Can propranolol act as a chemopreventive agent during oral carcinogenesis? An experimental animal study. ( Carrard, VC; Castilho, RM; Gaio, EJ; Nör, F; Rösing, CK; Spuldaro, TR; Wagner, VP, 2021) |
| "Treatment of multiple types of oral cancer cells with isoxsuprine led to the downregulation of mesenchymal cell markers that was accompanied by reduced cell motility." | 1.62 | Activation of β2-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells. ( Harada, H; Ishigami-Yuasa, M; Kagechika, H; Podyma-Inoue, KA; Sakakitani, S; Takahashi, K; Takayama, R; Watabe, T, 2021) |
| "The multistep process of oral carcinogenesis provides a biological rationale for the use of chemoprevention in individuals at increased risk of developing oral cancer." | 1.62 | Can propranolol act as a chemopreventive agent during oral carcinogenesis? An experimental animal study. ( Carrard, VC; Castilho, RM; Gaio, EJ; Nör, F; Rösing, CK; Spuldaro, TR; Wagner, VP, 2021) |
| "The propranolol treatment group exhibited a remarkable difference as compared with the other group." | 1.56 | The impact of propranolol on apoptosis in cutaneous squamous cell carcinomas. ( Celik, E; Kaplan, HM; Singirik, E, 2020) |
| "Propranolol treatment also enhanced the effects of γ-irradiation on cell viability." | 1.38 | Propranolol as a novel adjunctive treatment for head and neck squamous cell carcinoma. ( Enepekides, DJ; Irwin, MS; Wolter, JK; Wolter, NE, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bravo-Calderón, DM | 2 |
| Assao, A | 1 |
| Garcia, NG | 1 |
| Coutinho-Camillo, CM | 1 |
| Roffé, M | 1 |
| Germano, JN | 1 |
| Oliveira, DT | 2 |
| Sakakitani, S | 1 |
| Podyma-Inoue, KA | 1 |
| Takayama, R | 1 |
| Takahashi, K | 1 |
| Ishigami-Yuasa, M | 1 |
| Kagechika, H | 1 |
| Harada, H | 1 |
| Watabe, T | 1 |
| Wagner, VP | 1 |
| Spuldaro, TR | 1 |
| Nör, F | 1 |
| Gaio, EJ | 1 |
| Castilho, RM | 1 |
| Carrard, VC | 1 |
| Rösing, CK | 1 |
| Celik, E | 1 |
| Kaplan, HM | 1 |
| Singirik, E | 1 |
| Shang, ZJ | 1 |
| Liu, K | 1 |
| Liang, DF | 1 |
| Cavallasca, JA | 1 |
| Musuruana, JL | 1 |
| Granero, G | 1 |
| Vilardi, BM | 1 |
| Bernabé, DG | 1 |
| Oliveira, SH | 1 |
| Wolter, NE | 1 |
| Wolter, JK | 1 |
| Enepekides, DJ | 1 |
| Irwin, MS | 1 |
| Delavier-Klutchko, C | 1 |
| Hoebeke, J | 1 |
| Strosberg, AD | 1 |
| Martin, TJ | 1 |
| Nahorski, SR | 1 |
| Hunt, NH | 1 |
| Dawborn, JK | 1 |
| Loomes, RS | 1 |
| Underwood, CE | 1 |
| Kelly, LA | 1 |
| Butcher, RW | 1 |
| Hawkins, J | 1 |
| Lewis, HD | 1 |
| Emmot, W | 1 |
| Vacek, JL | 1 |
| Klein, S | 1 |
| Wolfe, RR | 1 |
| Bijman, JT | 1 |
| Wagener, DJ | 1 |
| van Rennes, H | 1 |
| Wessels, JM | 1 |
| Ramaekers, FC | 1 |
| van den Broek, P | 1 |
| Wang, L | 1 |
| Chorev, M | 1 |
| Feingers, J | 1 |
| Levitzki, A | 1 |
| Inbar, M | 1 |
15 other studies available for propranolol and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Beta adrenergic receptor activation inhibits oral cancer migration and invasiveness.
Topics: Adrenergic beta-Antagonists; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Mouth Neoplasms; Ne | 2020 |
Activation of β2-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells.
Topics: Androgen Receptor Antagonists; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; C | 2021 |
Can propranolol act as a chemopreventive agent during oral carcinogenesis? An experimental animal study.
Topics: 4-Nitroquinoline-1-oxide; Animals; Carcinogenesis; Carcinogens; Carcinoma, Squamous Cell; Disease Mo | 2021 |
The impact of propranolol on apoptosis in cutaneous squamous cell carcinomas.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Cha | 2020 |
Expression of beta2-adrenergic receptor in oral squamous cell carcinoma.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonist | 2009 |
Portal vein thrombosis in systemic lupus erythematosus associated with anticardiolipin antibodies.
Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Antirheumatic Agents; Carcinoma, Squamous Cell; | 2011 |
VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors.
Topics: Adrenergic beta-Antagonists; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Mouth Neoplasms; Ne | 2013 |
Propranolol as a novel adjunctive treatment for head and neck squamous cell carcinoma.
Topics: Adrenergic beta-Antagonists; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumo | 2012 |
The human carcinoma cell line A431 possesses large numbers of functional beta-adrenergic receptors.
Topics: Adrenergic beta-Antagonists; Binding, Competitive; Carcinoma, Squamous Cell; Cell Line; Dihydroalpre | 1984 |
Characterization of beta-adrenergic receptor linked to adenylate cyclase in a human cancer cell line (COLO 16).
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Carcinoma, Squamous Cell; Cell Line; Cyclic AMP; Enzyme | 1978 |
Studies on cyclic AMP metabolism in human epidermoid carcinoma (HEp-2) cells.
Topics: Adenosine; Adenylyl Cyclases; Adrenocorticotropic Hormone; Carcinoma, Squamous Cell; Cell Line; Cycl | 1975 |
Vasodepressive carotid sinus hypersensitivity with head and neck malignancy: treatment with propranolol.
Topics: Carcinoma, Squamous Cell; Carotid Sinus; Humans; Hypotension; Laryngeal Neoplasms; Male; Middle Aged | 1991 |
Whole-body lipolysis and triglyceride-fatty acid cycling in cachectic patients with esophageal cancer.
Topics: Adult; Aged; Cachexia; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fatty Acids; Female; Glycerol | 1990 |
Modulation of placental alkaline phosphatase activity and cytokeratins in human HN-1 cells by butyrate, retinoic acid, catecholamines and histamine.
Topics: Alkaline Phosphatase; Butyrates; Butyric Acid; Carcinoma, Squamous Cell; Catecholamines; Cell Divisi | 1987 |
Stereospecific antibodies to propranolol.
Topics: Antibodies, Monoclonal; Binding, Competitive; Carcinoma, Squamous Cell; Cell Line; Enzyme-Linked Imm | 1986 |